EX-32.1 5 tv506085_ex32-1.htm EXHIBIT 32.1


Exhibit 32.1




Certification Pursuant to 18 U.S.C. Section 1350, as Adopted


Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the filing of the quarterly report on Form 10-Q for the quarter ended September 30, 2018 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies that:


1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and


2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: November 14, 2018 /s/ Michael Macaluso
  Michael Macaluso
  Chairman and Chief Executive Officer
Dated: November 14, 2018 /s/ Thomas E. Chilcott, III
  Thomas E. Chilcott, III
  Chief Financial Officer, Treasurer and Secretary